journal article·2025-05

Preparation of stable liquid disperse dye using the antisolvent precipitation method for enhancing dyeability and eco-friendliness

Ziting Ma, Fuyang Gu, Xiaoyan Wang, Guowei Xiao, Yang Jiang, Jinmei Du, Liang He, Yongjun Yu, Xiyu Song, Changhai Xu

Dyes and Pigments· Volume 236
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Dyeing and Modifying Textile Fibers · Crystallization and Solubility Studies · Surfactants and Colloidal Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. The development of liquid disperse dye and its application
2. Preparation of liquid disperse dyes and related status quo
3. Preparation and application of liquid disperse dyes
4. Technology progress and application prospects of liquid disperse dyes
5. Formulation and characterization of ursodeoxycholic acid nanosuspension based on bottom-up technology and Box-Behnken design optimization10.3390/pharmaceutics15082037 ↗
6. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology10.1016/j.ejpb.2004.03.022 ↗
7. Nanonization techniques to overcome poor water-solubility with drugs10.1080/17460441.2020.1750591 ↗
8. Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling10.1016/j.ijpharm.2007.02.005 ↗
9. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology10.1016/j.addr.2010.12.007 ↗
10. Research progress in nanocrystal drug preparation technology. China Powder Science and Technology
11. Recent progress in antisolvent crystallization10.1039/D2CE00059H ↗
12. Molecular aspects of glycine clustering and phase separation in an aqueous solution during anti-solvent crystallization10.1039/D0CE00542H ↗
13. Antisolvent crystallization: model identification, experimental validation and dynamic simulation10.1016/j.ces.2008.08.003 ↗
14. Antisolvent crystallization of a cardiotonic drug in ionic liquids: effect of mixing on the crystal properties10.1016/j.jcrysgro.2016.12.057 ↗
15. In-line monitoring and interpretation of an indomethacin anti-solvent crystallization process by near-infrared spectroscopy (NIRS)10.1016/j.ijpharm.2011.08.044 ↗
16. Underlying mechanism of inkjet printing of uniform organic semiconductor films through antisolvent crystallization10.1002/adfm.201500802 ↗
17. Environmental modification of cellulose fibers for reducing dye diffusion rate by anionic polyacrylamide10.1016/j.polymer.2024.127814 ↗
18. Comprehensive analysis of dye adsorption and supramolecular interaction between dyes and cotton fibers in non-aqueous media/less water dyeing system10.1016/j.indcrop.2024.119955 ↗
19. Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method10.1016/j.ijpharm.2007.04.025 ↗
20. Efficient zero wastewater and salt-free of cotton fiber dyeing via hydrophobic organic chemical/water two-phase dyeing system10.1016/j.jclepro.2024.141886 ↗
21. Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening10.1021/la0523661 ↗
22. Recent progress in antisolvent crystallization10.1039/D2CE00059H ↗
23. Stability of dye dispersions in the presence of various surface active agents and additives10.1080/01932691.2012.660777 ↗
24. Three-step mechanism of antisolvent crystallization Published as part of a crystal growth & Design virtual special issue on emerging investigators 202210.1021/acs.cgd.2c00014 ↗
25. Strategies to control the particle size distribution of poly-ε-caprolactone nanoparticles for pharmaceutical applications10.1016/j.jcis.2008.03.033 ↗
26. Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size10.1016/j.ijpharm.2013.01.019 ↗
27. Polymer-mediated anti-solvent crystallization of nitrendipine: monodispersed spherical crystals and growth mechanism10.1007/s11095-011-0522-6 ↗
28. A printing color paste and its preparation method and application
29. Preparation, characterization, and evaluation of breviscapine nanosuspension and its freeze-dried powder10.3390/pharmaceutics14050923 ↗
30. Preparation of All-Trans Retinoic Acid nanosuspensions using a modified precipitation method10.1080/03639040500534184 ↗
31. Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution10.1016/S0378-5173(02)00147-3 ↗
32. Tuning membrane properties to control supersaturation of antisolvent crystallization10.1016/j.memsci.2024.122415 ↗
33. Crystallization and precipitation10.1016/S0255-2701(99)00025-2 ↗
34. Liquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: recent developments and future perspective10.1016/j.cej.2011.12.044 ↗
35. Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization10.1016/j.ejpb.2007.10.014 ↗
36. The effect of particle size distribution on dissolution rate and oral absorption10.1016/0378-5173(89)90069-0 ↗
37. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability10.1016/j.ejps.2010.04.006 ↗
38. Nucleation and growth in solution synthesis of nanostructures-From fundamentals to advanced applications10.1016/j.pmatsci.2021.100821 ↗
39. Controlled liquid antisolvent precipitation of hydrophobic pharmaceutical nanoparticles in a microchannel reactor10.1021/ie070498e ↗
40. Crystal growth kinetics10.1016/0025-5416(84)90194-0 ↗
41. Salt-free dyeing of cotton fabric and adsorption of reactive dyes in non-aqueous dyeing system: equilibrium, kinetics, and thermodynamics10.1007/s10570-022-04576-9 ↗